Does GLP-1RA Prevent Deterioration of Metabolic State in Prediabetic and Diabetic Patients Treated With Antipsychotic Medication?

Clinical trial NCT04892199 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT04892199
Sponsor: Anders Fink-Jensen, MD, DMSci
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 4
Study type: INTERVENTIONAL

Metabolic Disturbance Schizophrenia Type 2 Diabetes Clozapine GLP-1 Olanzapine

Start date: 2021-09-01
Primary completion: 2026-03-01
Enrollment: 104

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.